Using a promiscuous inhibitor to uncover cancer drug targets
Thursday, April 4, 2019 - 13:02
in Health & Medicine
Scientists at Harvard Medical School and the Dana-Farber Cancer Institute have developed a method that exploits the multitargeted nature of a chemical inhibitor to pinpoint vulnerabilities within cancer cells.